A Study in Healthy Men to Test How Well Different Doses of BI 1839100 Are Tolerated (1490-0001)

NCT05354453 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

104

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: BI 1839100
DRUG: Placebo
DRUG: allyl isothiocyanate (AITC)

Sponsor

Boehringer Ingelheim